Survey of the Anti-Factor IX Immunoglobulin Profiles in Patients With Hemophilia B Using a Fluorescence-Based Immunoassay
Supporting Files
-
10 2016 ; 10-2016
-
Available in CDC Stacks on 2017-10-01T00:00:00Z
File Language:
English
Details
-
Alternative Title:J Thromb Haemost
-
Personal Author:
-
Description:Background ; Hemophilia B (HB) is an inherited bleeding disorder caused by the absence or dysfunction of coagulation factor IX (FIX). A subset of patients who have HB develop neutralizing alloantibodies (inhibitors) against FIX following infusion therapy. HB prevalence and the proportion of patients who develop inhibitors are much lower than that of hemophilia A (HA), which makes studies of inhibitors in patients with HB challenging due to the limited availability of samples. As a result, there is a knowledge gap regarding HB inhibitors. ; Objective ; Evaluate the largest group of inhibitor positive HB patients studied to date to assess the relationship between anti-FIX antibody profiles and inhibitor formation. ; Methods ; A fluorescence immunoassay (FLI) was used to detect anti-FIX antibodies in plasma samples from 37 patients with HB. ; Results ; Assessments of antibody profiles showed that anti-FIX IgG1-4, IgA, and IgE were detected significantly more often in patients with a positive Nijmegen-Bethesda Assay (NBA). All NBA-positive samples were positive for IgG4. Anti-FIX IgG4 demonstrated a strong correlation with the NBA, while correlations were significant, yet more moderate, for anti-FIX IgG1-2 and IgA. ; Conclusions ; The anti-FIX antibody profile in HB patients who develop inhibitors is diverse and correlates well with the NBA across immunoglobulin (sub)class, and anti-FIX IgG4 is particularly relevant to functional inhibition. The anti-FIX FLI may serve as a useful tool to confirm the presence of antibodies in patients who have low positive NBA results and to more clearly define, predict, and treat alloantibody formation against FIX.
-
Subjects:
- Adolescent
- Adult
- Aged
- Antibodies, Neutralizing
- Blood Coagulation
- Case-Control Studies
- Child
- Child, Preschool
- Cross-Sectional Studies
- Factor IX
- Fluorescent Antibody Technique
- Hemophilia B
- Humans
- Immunoglobulin G
- Immunoglobulins
- Infant
- Isoantibodies
- Middle Aged
- Prevalence
- Severity of Illness Index
- Young Adult
-
Keywords:
-
Source:J Thromb Haemost. 14(10):1931-1940
-
Pubmed ID:27501440
-
Pubmed Central ID:PMC5083216
-
Document Type:
-
Funding:
-
Volume:14
-
Issue:10
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:587757a52697d3c9a8df25349587295d09addc5927afdcdd3e4dde43ce29e4d4
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access